Saxagliptin Hydrochloride

CAS 709031-78-7 10 current records 3 historicalSmall Molecule

Who holds supplier records for Saxagliptin Hydrochloride? 10 organisations hold a current record for Saxagliptin Hydrochloride: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (6), China (1), Netherlands (1) and Switzerland (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Saxagliptin Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/saxagliptin-hydrochloride

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    6 of the 9 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Saxagliptin Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India6China1Netherlands1Switzerland1Country not recorded for 1
Need Saxagliptin Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (3)

Organisations whose Type II DMFs for Saxagliptin Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 3 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Saxagliptin Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201743).

Chemical identity

IUPAC name
(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;hydrochloride
Canonical SMILES
C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N.Cl
InChIKey
TUAZNHHHYVBVBR-NHKADLRUSA-N
Synonyms
Onglyza, Saxagliptin hcl, Saxagliptin hydrochloride, Saxagliptin hydrochloride component of kombiglyze, Saxagliptin hydrochloride component of qtern, Saxagliptin hydrochloride component of qternmet xr, SAXAGLIPTIN HYDROCHLORIDE (MART.), SAXAGLIPTIN HYDROCHLORIDE [MART.], RefChem:56928, C18H26ClN3O2, Saxagliptin (hydrochloride), Onglyza (TN)

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Dipeptidyl Peptidase 4 Inhibitor
Mechanism of action
Dipeptidyl Peptidase 4 Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Saxagliptin Hydrochloride?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Saxagliptin Hydrochloride: MOREPEN LABORATORIES LTD (India), BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD (China), Dr. Reddy's Laboratories Ltd. (India), FUXIN LONG RUI PHARMACEUTICAL CO LTD, MATRIX PHARMACORP PRIVATE LTD (India), METROCHEM API PRIVATE LTD (India), MSN PHARMACHEM PRIVATE LTD (India) and RAKS PHARMA PVT LTD (India), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Saxagliptin Hydrochloride Drug Master Files are active?

MOREPEN LABORATORIES LTD (DMF 33635, 35690), BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD (DMF 29299), Dr. Reddy's Laboratories Ltd. (DMF 27212), FUXIN LONG RUI PHARMACEUTICAL CO LTD (DMF 33486), MATRIX PHARMACORP PRIVATE LTD (DMF 27146), METROCHEM API PRIVATE LTD (DMF 42492), MSN PHARMACHEM PRIVATE LTD (DMF 27239) and RAKS PHARMA PVT LTD (DMF 27189) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Saxagliptin Hydrochloride records mean?

3 organisations have only inactive Type II DMFs for Saxagliptin Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Saxagliptin Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Saxagliptin Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.